He, Siyu
Jin, Yinuo http://orcid.org/0000-0003-1889-8587
Nazaret, Achille http://orcid.org/0000-0002-5428-9810
Shi, Lingting
Chen, Xueer http://orcid.org/0000-0002-7503-6388
Rampersaud, Sham http://orcid.org/0000-0001-7473-4144
Dhillon, Bahawar S. http://orcid.org/0009-0005-1825-5356
Valdez, Izabella
Friend, Lauren E.
Fan, Joy Linyue
Park, Cameron Y.
Mintz, Rachel L.
Lao, Yeh-Hsing http://orcid.org/0000-0002-7990-199X
Carrera, David
Fang, Kaylee W.
Mehdi, Kaleem
Rohde, Madeline
McFaline-Figueroa, José L. http://orcid.org/0000-0003-4387-1511
Blei, David
Leong, Kam W.
Rudensky, Alexander Y. http://orcid.org/0000-0003-1280-2898
Plitas, George http://orcid.org/0000-0002-8357-9534
Azizi, Elham http://orcid.org/0000-0001-5059-6971
Article History
Received: 21 November 2022
Accepted: 14 February 2024
First Online: 21 March 2024
Competing interests
: A.Y.R. is an SAB member for Coherus, Amgen, Sonoma Biotherapeutics, Santa Ana Bio, Vedanta Biosciences, RAPT Therapeutics and BioInvent. G.P. is an SAB member for Merck, Tizona, Trishula and Paige.AI. A.Y.R. and G.P. have IP on intratumoral T<sub>reg</sub> cell depletion licensed to Takeda. The other authors declare no competing interests.